ACG临床指南:肝性脑病
美国胃肠病学院(ACG)发布肝性脑病临床指南,采用GRADE方法评估证据质量,提出24条关于肝性脑病诊断、管理和预防策略的推荐。指南指出肝性脑病是肝硬化重大负担性并发症,其从隐匿性到显性疾病的进展未充分反映在当前移植列表标准中,导致许多患者尽管生活质量严重受损仍未被充分优先考虑移植。
要点
- 肝性脑病是肝硬化重大负担性并发症,影响患者、家庭和医疗系统。
- 指南提出24条诊断、管理和预防推荐,采用GRADE方法评估证据质量。
- 肝性脑病进展未充分反映在移植列表标准中,部分患者移植优先级不足。
核心结论
- 肝性脑病是肝硬化重大负担性并发症,其进展未充分反映在当前移植列表标准中,导致部分患者移植优先级不足。
研究设计与样本
- 美国胃肠病学院(ACG)制定的临床指南,采用GRADE方法评估证据质量,提出24条推荐。
主要发现
- 肝性脑病从隐匿性到显性疾病的进展未充分反映在当前移植列表标准中,许多患者尽管生活质量严重受损仍未被充分优先考虑移植。
关键数值与推荐
- 指南提出24条关于肝性脑病诊断、管理和预防策略的推荐,采用GRADE方法评估证据质量。
- 对未应用GRADE过程的陈述提供关键概念。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatic encephalopathy is a major and burdensome complication of cirrhosis, with significant consequences for patients, families, and healthcare systems. Its progression from covert to overt disease is not fully reflected in current transplant listing criteria, leaving many patients inadequately prioritized for transplantation despite substantial impairment in quality of life. This guideline of the American College of Gastroenterology presents 24 recommendations for the diagnosis, management, and prevention strategies for hepatic encephalopathy. The Grading of Recommendations, Assessment, Development, and Evaluation process was used to assess the quality of evidence for each statement. Key concepts are also provided for statements to which the Grading of Recommendations, Assessment, Development, and Evaluation process has not been applied.
引用
- Bajaj JS, Jakab SS, Jesudian AB, et al. ACG Clinical Guideline: Hepatic Encephalopathy. Am J Gastroenterol. 2026. PMID: 41773757. doi:10.14309/ajg.0000000000003899
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。